If ACL is currently only valued on the Synthetic Heparin (which it is) then what value willbe place on HyCamp? ACL are off to ASCO to generate support for a Phase 3 FDA submission and based on their results they should get it.
Also,the HyAct platform has scope beyond the current trial area so it will be interesting to see how it gets valued now that the results are out in the open.
My thoughts only, but I like the way things are building for ACL.
If ACL is currently only valued on the Synthetic Heparin (which...
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable